Johns Hopkins University
Baltimore, Maryland, 21231, United States
NCT Number: NCT01169207
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a idiopathic, chronic and frequently disabling inflammatory disorder of the intestines characterized by a dysregulated mucosal immune response that affect more than a million Americans. This current protocol was established in 1996 with the goal of identifying the genetic and environmental components that contribute to the development of IBD, especially in families.
This study is active but is not currently recruiting participants.
5 year and older
All sexes
Observational
Baltimore, Maryland, 21231, United States
The investigators initiated this research study in 1996 with the overall goal of identifying IBD susceptibility genes. In the beginning, the major focus was recruitment of multiply affected IBD pedigrees for linkage studies, but the investigators have since expanded the study to include singleton cases and spousal/friend as well as population controls for comparison purposes The investigator's recruitment goal is 2500 subjects.
Blood samples obtained from participants are used to isolate lymphocytes for storage, serum for serological analysis of antibodies and other proteins relevant to IBD and DNA for genotyping or sequencing. Lymphocytes may be transformed with EBV to establish immortalized lymphoblastoid cell lines. These cell lines can be used as a secondary DNA source or to study IBD relevant gene, protein expression and cell function
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
ADULTS:
CHILDREN:
Exclusion criteria
Time frame: Single visit, approximately 1 hour
Johns Hopkins University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01169194
Colitis, Colitis, Ulcerative
Baltimore, Maryland, United States
View Trial DetailsNCT07619547
Colitis, Colitis, Ulcerative
Bethesda, Maryland, United States
View Trial DetailsNCT07242248
Colitis, Colitis, Ulcerative
Harrow, United Kingdom
View Trial DetailsNCT07102368
Colitis, Colitis, Ulcerative
Berlin, Germany
View Trial Details